Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC Berkeley-led team of researchers may have solved this delivery bottleneck, potentially opening the door to novel, lifesaving treatments.
